Vagner S, Rüegsegger U, Gunderson S I, Keller W, Mattaj I W
European Molecular Biology Laboratory, Heidelberg, Germany.
RNA. 2000 Feb;6(2):178-88. doi: 10.1017/s1355838200991854.
The 3' ends of most eukaryotic pre-mRNAs are generated by 3' endonucleolytic cleavage and subsequent polyadenylation. 3'-end formation can be influenced positively or negatively by various factors. In particular, U1 snRNP acts as an inhibitor when bound to a 5' splice site located either upstream of the 3'-end formation signals of bovine papilloma virus (BPV) late transcripts or downstream of the 3'-end processing signals in the 5' LTR of the HIV-1 provirus. Previous work showed that in BPV it is not the first step, 3' cleavage, that is affected by U1 snRNP, but rather the second step, polyadenylation, that is inhibited. Since in HIV-1 the biological requirement is to produce transcripts that read through the 5' LTR cleavage site rather than being cleaved there, this mechanism seemed unlikely to apply. The obvious difference between the two examples was the relative orientation of the 3'-end formation signals and the U1 snRNP-binding site. In vitro assays were therefore used to assess the effect of U1 snRNP bound at various locations relative to a cleavage/polyadenylation site on the 3' cleavage reaction. U1 snRNP was found to inhibit cleavage when bound to a 5' splice site downstream of the cleavage/polyadenylation site, as in the HIV-1 LTR. U1 snRNP binding at this location was shown not to affect the recruitment of multiple cleavage/polyadenylation factors to the cleavage substrate, indicating that inhibition is unlikely to be due to steric hindrance. Interactions between U1A, U1 70K, and poly(A) polymerase, which mediate the effect of U1 snRNP on polyadenylation of other pre-mRNAs, were shown not to be required for cleavage inhibition. Therefore, U1 snRNP bound to a 5' splice site can inhibit cleavage and polyadenylation in two mechanistically different ways depending on whether the 5' splice site is located upstream or downstream of the cleavage site.
大多数真核生物前体mRNA的3'末端是通过3'核酸内切酶切割和随后的多聚腺苷酸化产生的。3'末端的形成可受到各种因素的正向或负向影响。特别是,当U1 snRNP与位于牛乳头瘤病毒(BPV)晚期转录本3'末端形成信号上游的5'剪接位点或HIV-1原病毒5' LTR中3'末端加工信号下游的5'剪接位点结合时,它作为一种抑制剂发挥作用。先前的研究表明,在BPV中,受U1 snRNP影响的不是第一步,即3'切割,而是第二步,即多聚腺苷酸化,受到抑制。由于在HIV-1中,生物学要求是产生通读5' LTR切割位点而不是在该位点被切割的转录本,这种机制似乎不太可能适用。这两个例子之间的明显差异是3'末端形成信号和U1 snRNP结合位点的相对方向。因此,体外试验用于评估相对于切割/多聚腺苷酸化位点在不同位置结合的U1 snRNP对3'切割反应的影响。如在HIV-1 LTR中一样,发现当U1 snRNP与切割/多聚腺苷酸化位点下游的5'剪接位点结合时会抑制切割。U1 snRNP在此位置的结合并未影响多种切割/多聚腺苷酸化因子募集到切割底物上,这表明抑制不太可能是由于空间位阻。介导U1 snRNP对其他前体mRNA多聚腺苷酸化作用的U1A、U1 70K和多聚(A)聚合酶之间的相互作用,对于切割抑制并非必需。因此,根据5'剪接位点是位于切割位点的上游还是下游,与5'剪接位点结合的U1 snRNP可以通过两种机制不同的方式抑制切割和多聚腺苷酸化。